Brief: SK Biopharmaceuticals Says To Acquire 177 Billion Won Worth Of Shares In Ignis Therapeutics
Nov 11 (Reuters) -
* SK BIOPHARMACEUTICALS: TO ACQUIRE 177 BILLION WON WORTH OF
SHARES IN IGNIS THERAPEUTICS
Further company coverage: 326030.KS
(Reporting by Joyce Lee)
((JungYoon.Lee@thomsonreuters.com;))
Recent news on SK Biopharmaceuticals Co
See all newsInsilico Medicine hits 3-week high on SK Biopharmaceuticals tie-up
Signs Joint Rd Partnership Agreement With Insilico Medicine
Brief: Insilico Medicine Cayman TopCo Says Co & SK Biopharmaceuticals Enter AI-Powered RD Collab Worth Up To $2.5 Bln
Brief: SK Life Science Announces FDA Acceptance For Review Of New Drug Application For Cenobamate Oral Suspension
Announces Pharmaceutical Supply Contract